Effectiveness of Attention Focus Training on Attention and Quality of Life in Stroke
NCT07668245, Not applicable, Active not recruiting, Shifa Tameer-e-Millat University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effectiveness of Attention Focus Training on Attention and Quality of Life in Stroke | ClinicalTrials.gov |
| NCT number | NCT07668245 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 46 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Shifa Tameer-e-Millat University | ClinicalTrials.gov |
| Conditions | Stroke | ClinicalTrials.gov |
| Interventions | Exercise, Conventional | ClinicalTrials.gov |
| First posted | 2026-06-25 | ClinicalTrials.gov |
| Last updated | 2026-10-13 | ClinicalTrials.gov |
Registered outcomes 3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Stroop Color-Word Test | Baseline and post 4 weeks of intervention | It consists of three conditions/sheets: (i) Word (W), in which the participant reads color words; (ii) Color (C), in which they name the ink colors; (iii) Color-Word (CW), in which they name the ink color while inhibiting the tendency to read the conflicting word. Responses are recorded and calculated for all three sheets. Scores are based on the number of correct responses within the specified time (45 minutes), with higher scores indicating better performance. | ClinicalTrials.gov |
| Primary | Trail Making Test Test (A & B) | Baseline & post 4 weeks of intervention | Trial Making Test (TMT) consists of two parts (TMT-A \& TMT-B). For TMT-A, participants connect numbers in sequential order (e.g. 1-2-3-4). For TMT-B, participants alternate between numbers and letters (e.g. 1-A-2-B-3-C). Participants are instructed to completed each task as quickly and accurately as possible. Score is primarily the time in seconds to complete the task. Lower time denotes better performance. | ClinicalTrials.gov |
| Primary | Stroke Impact Scale | Baseline and post 4 weeks of intervention | Stroke Impact Scale (SIS) scores range from 0 to 100 for each domain. A score of 0 indicates greatest impact of stroke or complete inability to perform tasks within that domain, while a score of 100 indicates no disability, no difficulty performing tasks, and the best possible outcome. Higher scores indicate better functioning and less impact of stroke. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)